Research advances of Elabela in kidney disease

Elabela is a new endogenous peptidic ligand for G protein-coupled receptor-APJ with a strong sequence homology with angiotensin type 1 receptor（AT1）.Conjugating with its receptor Apelin-angiotensin receptor-like（APJ）to exert a series of biological effects, Elabela is predominantly expressed in adult...

Full description

Bibliographic Details
Published in:	Linchuang shenzangbing zazhi
Main Authors:	Wang Zi-wei, Shi Min, Chen Juan, Zhang Hong
Format:	Article
Language:	Chinese
Published:	Editorial Department of Journal of Clinical Nephrology 2021-01-01
Subjects:	Elabela Acute kidney injury Hypertensive renal disease Diabetic nephropathy
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57902793&Fpath=home&index=0

Similar Items

Advances in the study of ELABELA in renal physiological functions and related diseases
by: YuRong Liu, et al.
Published: (2023-10-01)

Maternal Plasma Elabela, a Biomarker for the Severity and Kidney Function of Human Preeclampsia
by: Miaoyan Ma, et al.
Published: (2022-09-01)

Serum Elabela expression is decreased in hypertensive patients and could be associated with the progression of hypertensive renal damage
by: Geng Tian, et al.
Published: (2024-02-01)

Elabela: novel perspectives on vascular physiology and disease
by: Hendrianus, et al.
Published: (2022-12-01)

The potential of serum elabela levels as a marker of diabetic retinopathy: results from a pilot cross-sectional study
by: Muhammed Seyithanoğlu, et al.
Published: (2025-01-01)

Serum elabela levels in women with tubal ectopic pregnancy: A case-control study
by: Evrim Gul, et al.
Published: (2020-06-01)

Elabela: Negative Regulation of Ferroptosis in Trophoblasts via the Ferritinophagy Pathway Implicated in the Pathogenesis of Preeclampsia
by: Huan Yang, et al.
Published: (2022-12-01)

Evaluation of Apelin, Elabela, and Certain Biomarkers in Patients with Metabolic Disease Associated with Obesity
by: Layla Imad Ali, et al.
Published: (2025-06-01)

Elabela Protects Spontaneously Hypertensive Rats From Hypertension and Cardiorenal Dysfunctions Exacerbated by Dietary High-Salt Intake
by: Xavier Sainsily, et al.
Published: (2021-07-01)

Predicting late‐onset preeclampsia by detecting ELABELA content using an immunochromatographic colloidal gold test strip
by: Na Yang, et al.
Published: (2023-10-01)

The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect?
by: Natalia Respekta, et al.
Published: (2022-12-01)

ELABELA Ameliorates Atherosclerosis Through Restoring the M1/M2 Macrophage Balance in ApoE−/− Mice
by: Le Tang, et al.
Published: (2025-07-01)

Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study
by: Chunju Liu, et al.
Published: (2024-05-01)

Elabela Attenuates Doxorubicin-Induced Oxidative DNA Damage and Apoptosis in Rat Left Ventricular Myocardium
by: Katarzyna Matusik, et al.
Published: (2025-09-01)

Sexual Dimorphism in the Polarization of Cardiac ILCs through Elabela
by: Évila Lopes Salles, et al.
Published: (2022-12-01)

Declined circulating Elabela levels in patients with essential hypertension and its association with impaired vascular function: A preliminary study
by: Yutao Li, et al.
Published: (2020-04-01)

Serum Elabela Level as a Reliable Biomarker for Predicting of Liver Fibrosis in Iraqi Patients with Chronic Hepatitis C
by: Eham Amer Ali, et al.
Published: (2024-07-01)

Uma Nova Via para Oclusão Coronariana com Elabela?
by: Ricardo Wang, et al.
Published: (2021-09-01)

Circulating Apelin-17 and Elabela Levels as Predictive Biomarkers of Neurodegeneration and Cognitive Decline in Alzheimer’s Disease
by: Shaimaa Imad Ali, et al.
Published: (2025-07-01)

Elabela increases in patients with primary hyperparathyroidism, especially in the presence of surgery indication
by: Kubilay Akbal, et al.
Published: (2025-09-01)

Myonectin, irisin, apelin-13 and Elabela hormones levels as biomarkers for type 2 diabetes mellitus : a systematic review
by: Abdullah A. H. Al-Rubaye, et al.
Published: (2024-08-01)

Alpha-lipoic acid: A promising pharmacotherapy seen through the lens of kidney diseases
by: George J. Dugbartey, et al.
Published: (2024-01-01)

Fc-Elabela mitigates heart failure without liver and renal toxicity in mice
by: Huifen Zhou, et al.
Published: (2025-07-01)

The Value of Serum Elabela in Preeclamptic Women with and without Fetal Growth Restriction at 34 Weeks of Pregnancy: A Case–Control Study
by: Eham Amer Ali, et al.
Published: (2025-01-01)

Stem/Stromal Cells for Treatment of Kidney Injuries With Focus on Preclinical Models
by: Adriana Torres Crigna, et al.
Published: (2018-06-01)

ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathway
by: Jing-Yu Hou, et al.
Published: (2025-02-01)

Type 2 innate lymphoid cell and kidney disease
by: Yao Deng-hu, et al.
Published: (2021-01-01)

G-Protein-Coupled Receptors in Chronic Kidney Disease Induced by Hypertension and Diabetes
by: Huidi Tang, et al.
Published: (2025-05-01)

Polyphenols and Their Metabolites in Renal Diseases: An Overview
by: Íris Guerreiro, et al.
Published: (2022-04-01)

Disrupted Alpha-Ketoglutarate Homeostasis: Understanding Kidney Diseases from the View of Metabolism and Beyond
by: Guo L, et al.
Published: (2022-06-01)

Elabela alleviates cuproptosis and vascular calcification in vitaminD3- overloaded mice via regulation of the PPAR-γ /FDX1 signaling
by: Rui-Qiang Qi, et al.
Published: (2024-11-01)

A glimpse of recent advances in the research of acute kidney injury
by: Zheng Dong, et al.
Published: (2023-06-01)

IL-17C neutralization protects the kidney against acute injury and chronic injuryResearch in context
by: Fangfei Zhang, et al.
Published: (2023-06-01)

Therapeutic advances in the management of chronic kidney disease: A look at the last 10 years.
by: Ibtissame ARBAOUI
Published: (2024-06-01)

Autophagy Function and Regulation in Kidney Disease
by: Gur P. Kaushal, et al.
Published: (2020-01-01)

Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
by: Tingting Li, et al.
Published: (2021-02-01)

Significant Calcification of an Entire Aortic Tree with Renal Artery Subocclusion: Acute Kidney Injury, Ischemic Kidney Disease, and the Tissue Viability Question—A Case Report
by: Marko Baralić, et al.
Published: (2025-01-01)

Pharmacological functions of salidroside in renal diseases: facts and perspectives
by: Qiong Liu, et al.
Published: (2024-01-01)

Risk factors and predictive model for renal outcomes in autoimmune membranous nephropathy with and without acute kidney injury: a retrospective cohort study
by: Zhenzhou Li, et al.
Published: (2025-04-01)

Associação entre os Níveis Séricos de Elabela e Oclusão Total Crônica em Pacientes com Angina Pectoris Estável
by: Fethi Yavuz, et al.
Published: (2021-05-01)